Lytix Biopharma AS Stock (OSE:LYTIX)


kr -
Today's Range
kr - - kr -
52-Week Range
kr 7.80 - kr 16.70
Market Cap
kr 360.61M

About Lytix Biopharma As (OSE:LYTIX)

(OSE:LYTIX) Lytix Biopharma ASA, a clinical stage biotech company, engages in the research and development of medicines for cancer indications based on immunotherapy in Norway. Its lead product candidate is LTX-315, an oncolytic peptide with potent immunomodulatory properties, is designed for the local treatment of solid tumors that is in Phase II clinical trials. The company's products also include LTX-401, an oncolytic pipeline product, is a low-molecular drug that is designed for deep-seated visceral tumors and is in a preclinical phase. The company was founded in 2003 and is based in Oslo, Norway.
Show more

LYTIX Stock Price

Statistics Highlights (OSE:LYTIX)

Shares Outstanding 40.07M Beta -
Public Float 14.70M P/E Ratio -
% Short of Float - Dividend (Yield) -
Held by Insiders 54.78% Ex-Dividend Date
Held by Institutions - IPO Date -

LYTIX Financial Summary

Dec 21 Dec 20 Dec 19
Revenue kr17.00K kr3.00K kr310.00K
EBITDA kr-48.05M kr-42.37M kr-33.76M
Net Income kr-48.05M kr-42.09M kr-33.23M
Total Assets kr202.96M kr32.62M kr17.43M
Total Cash kr197.28M kr27.15M kr12.05M
Total Debt kr kr kr
Mar 22 Dec 21 Sep 21
Revenue kr0.00 kr0.00 kr0.00
EBITDA kr-14.67M kr-16.40M kr-18.80M
Net Income kr-15.23M kr-16.39M kr-18.91M
Total Assets kr187.94M kr202.96M kr214.13M
Total Cash kr180.67M kr197.28M kr209.18M
Total Debt kr kr kr

(OSE:LYTIX) Stock Price FAQs

What is Lytix Biopharma As's 52-week change?

Lytix Biopharma As (OSE:LYTIX) FAQ

How Much is Lytix biopharma as Worth?

Lytix biopharma as's worth today based on market capitalisation is kr360.61M

How much dividend does Lytix biopharma as Pay?

The current annualized dividend payout for LYTIX stock is kr0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Lytix biopharma as's "Dividend" Section

What is Lytix biopharma as’s Price to Earning (PE) ratio?

LYTIX stock also has a Price to Sales (P/S) ratio of 56.95.

What is the Lytix biopharma as's ticker?

Lytix biopharma as trades on the Oslo stock market in Norway under the ticker symbol "LYTIX". Lytix biopharma as’s stock symbol can also be displayed as "OSE:LYTIX".

Who are the owners of Lytix biopharma as?

Lytix biopharma as (OSE:LYTIX) is owned by 0.00% institutional shareholders and by 54.78% insiders. The rest is owned by the public.
Explore More Details on Lytix biopharma as's “Ownership” Section

Who are the key executives of Lytix biopharma as (LYTIX)?

Lytix biopharma as's key executive team includes the following managers:

  • Dr. Oystein Rekdal, Co-Founder & CEO (NA)
  • Mr. Gjest Breistein M.Sc., Chief Financial Officer (NA)
  • Dr. Baldur Sveinbjørnsson Ph.D., Chief Scientific Officer (NA)
  • Dr. Gry Stensrud Ph.D., Chief Technology Officer (1970)
  • Dr. Andrew Saunders, Chief Medical Officer (1965)
  • Dr. Graeme Currie Ph.D., Chief Devel. Officer (NA)

What is Lytix biopharma as’s Sector & Industry Classification?

Lytix biopharma as (OSE:LYTIX) is classified under the "Healthcare" sector and under the "Biotechnology" industry.

How many employees work for Lytix biopharma as?

Currently the number of employees working for Lytix biopharma as is 8.

Where are Lytix biopharma as's Headquarters?

Lytix biopharma as (OSE:LYTIX) is headquartered in Norway.

What are Lytix biopharma as's Address and Phone Number?

Lytix biopharma as’s mailing address is Sandakerveien 138, Oslo, Norway, 0484.
The company’s phone number is 47 95 26 05 12.

What is the official website for Lytix biopharma as?

Lytix biopharma as’s official website is